Blend Labs (NYSE:BLND) Releases Earnings Results

Key Points

• Blend reported Q4 revenue of $32.4M and $5.4M non‑GAAP operating income, turned positive free cash flow, ended the year with $68.3M in cash and zero debt, repurchased ~5.1M shares (~$16M) and authorized a new $50M buyback.
• The company launched Blend Autopilot (agentic AI) with early adoption by seven large customers and says its pipeline is up ~40% YoY as deals shift toward bundled mortgage + consumer banking engagements.
• Management guided Q1 revenue to $28.5M–$30M (below Street), reported an EPS miss (‑$0.03 vs. $0.01 consensus), and disclosed a material weakness in internal control over revenue to be detailed in the upcoming 10‑K.

Blend Labs (NYSE:BLND - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.04), reports. The firm had revenue of $32.37 million for the quarter, compared to the consensus estimate of $31.78 million.

Here are the key takeaways from Blend Labs' conference call:

• Q4 results beat expectations with $32.4M revenue and $5.4M non‑GAAP operating income; free cash flow was positive, the company ended the year with $68.3M in cash/securities, zero debt, repurchased ~5.1M shares (~$16M) in Q4 and announced a new $50M buyback authorization.
• The company launched Blend Autopilot (agentic AI) on March 3 to automate “stare and compare” and complex guideline checks — seven large customers enabled it in the preview week, signaling early demand and a potential efficiency moat.
• Commercial momentum — Blend signed 10 Q4 deals/expansions, its pipeline is up ~40% YoY and is shifting toward bundled mortgage + consumer banking engagements, including a new seven‑figure top‑40 credit union logo.
• Q1 2026 guidance is for $28.5M–$30M revenue (6%–12% YoY) and $2M–$3M non‑GAAP operating income; management expects mortgage to lead growth, consumer banking to be muted, and EVPFL of ~$84–85, while ASU 2025‑06 changes mean non‑GAAP R&D will show ~$7M (up YoY) despite cash R&D actually falling ~15% — modelers should treat $7M as the new baseline.
• Management disclosed a material weakness in internal control over revenue for 2025 and made immaterial out‑of‑period revenue revisions; the company will include revised figures and disclosures in its upcoming 10‑K.

Blend Labs Stock Performance

Shares of NYSE:BLND traded up $0.28 during mid-day trading on Wednesday, reaching $1.91. 2,508,319 shares of the company's stock were exchanged, compared to its average volume of 3,273,495. Blend Labs has a twelve month low of $1.57 and a twelve month high of $4.49. The firm has a market capitalization of $494.82 million, a price-to-earnings ratio of -19.25 and a beta of 1.27. The business's fifty day moving average price is $2.33 and its 200-day moving average price is $3.02.

Insiders Place Their Bets

In related news, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $3.06, for a total value of $76,500.00. Following the completion of the sale, the insider directly owned 649,824 shares in the company, valued at $1,988,461.44. This represents a 3.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold 33,125 shares of company stock valued at $93,169 in the last three months. Corporate insiders own 35.52% of the company's stock.

Institutional Investors Weigh In On Blend Labs

A number of institutional investors have recently made changes to their positions in BLND. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Blend Labs in the third quarter valued at about $32,000. Captrust Financial Advisors acquired a new position in shares of Blend Labs in the second quarter worth approximately $35,000. Jump Financial LLC acquired a new position in shares of Blend Labs in the second quarter worth approximately $38,000. Cibc World Markets Corp bought a new stake in Blend Labs in the fourth quarter valued at approximately $40,000. Finally, Wexford Capital LP acquired a new stake in Blend Labs during the 3rd quarter valued at approximately $45,000. Institutional investors own 52.56% of the company's stock.

Wall Street Analysts Forecast Growth

BLND has been the topic of a number of research reports. Wall Street Zen upgraded Blend Labs from a "sell" rating to a "hold" rating in a research report on Sunday, November 16th. Citizens Jmp dropped their target price on Blend Labs from $7.00 to $5.00 and set a "market outperform" rating for the company in a research report on Wednesday. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Blend Labs in a research note on Wednesday, January 21st. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Blend Labs presently has a consensus rating of "Hold" and an average target price of $4.47.

Key Headlines Impacting Blend Labs

Here are the key news stories impacting Blend Labs this week:

• Positive Sentiment: Company announced a $50 million share buyback, which supports the stock and signals management confidence. Article Title
• Positive Sentiment: Q4 revenue beat — Blend reported $32.37M in revenue vs. analyst estimates of $31.78M, showing continued top-line growth that investors favor. Article Title
• Positive Sentiment: CEO commentary was strongly upbeat (“I have never been more excited”), which can bolster investor sentiment around execution and strategy. Article Title
• Neutral Sentiment: Citizens Jmp cut its price target from $7 to $5 but kept a “market outperform” rating — a mixed signal (lower target, but continued conviction). Article Title
• Negative Sentiment: EPS missed — Blend reported (‑$0.03) EPS vs. consensus of $0.01, which raises near-term profitability concerns. Article Title
• Negative Sentiment: FYQ1 revenue guidance came in below consensus: company guided $28.5M–$30.0M vs. Street ~$31.9M, which tempers the positive reaction and raises short-term growth concerns. Article Title
• Negative Sentiment: Analyst coverage is mixed/tepid — the average rating sits around “Hold,” which may limit sustained upside until guidance and profitability improve. Article Title

About Blend Labs

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend's platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company's product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.